富士製薬工業株式会社 · Pharmaceutical · FY ends Sep
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | FJP Ltd. | 4,307,000 | 17.58% | ¥6.7B | ¥196M |
| 2 | Hirofumi Imai | 3,052,000 | 12.46% | ¥4.7B | ¥139M |
| 3 | 日本マスタートラスト信託銀行株式会社 | 2,159,000 | 8.81% | ¥3.3B | ¥98.2M |
| 4 | Noriko Arai | 1,240,000 | 5.06% | ¥1.9B | ¥56.4M |
| 5 | Lotus Japan Holdings LLC | 1,219,000 | 4.98% | ¥1.9B | ¥55.5M |
| 6 | 株式会社日本カストディ銀行 | 1,046,000 | 4.27% | ¥1.6B | ¥47.6M |
| 7 | Yamhill Sciences Co., Ltd. | 1,000,000 | 4.08% | ¥1.5B | ¥45.5M |
| 8 | 今井 道子 | 446,000 | 1.82% | ¥689M | ¥20.3M |
| 9 | 公益財団法人今井精一記念財団 | 400,000 | 1.63% | ¥618M | ¥18.2M |
| 10 | 富士製薬工業従業員持株会 | 372,000 | 1.52% | ¥575M | ¥16.9M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| 岩井 孝之 | Chairman & Representative Director | 14,954 | ¥23.1M | — |
| Shuhei Morita | President & Representative Director | 4,241 | ¥6.6M | — |
| 上出 豊幸 | Executive Vice President & Director | 21,373 | ¥33.0M | — |
| 鈴木 聡 | Executive Vice President & Director | 1,304 | ¥2.0M | — |
| 平井 敬二 | Director | 6,900 | ¥10.7M | — |
| 三宅 峰三郎 | Director | 6,900 | ¥10.7M | — |
| 木山 啓子 | Director | 2,100 | ¥3.2M | — |
| 荒木 由季子 | Director | 1,000 | ¥1.5M | — |
| 小澤 実 | Director | 2,800 | ¥4.3M | — |
| 尾島 大司 | Full-time Audit & Supervisory Board Member | 8,600 | ¥13.3M | — |
| 三村 藤明 | Audit & Supervisory Board Member | 8,000 | ¥12.4M | — |
| 相良 美織 | Audit & Supervisory Board Member | 1,600 | ¥2.5M | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Sep 2025 | ¥1,545 | ¥122.94 | 12.6x | ¥45.5 | 24,891,100 |
| FY ending Sep 2024 | ¥1,272 | ¥252.85 | 5.0x | ¥42.5 | 24,753,800 |
| FY ending Sep 2023 | ¥1,166 | ¥141.37 | 8.2x | ¥37.0 | 24,753,800 |
| FY ending Sep 2022 | ¥1,034 | ¥111.01 | 9.3x | ¥35.0 | 24,753,800 |
| FY ending Sep 2021 | ¥1,170 | ¥90.54 | 12.9x | ¥29.0 | 24,753,800 |
| FY ending Sep 2020 | ¥1,249 | ¥66.94 | 18.7x | ¥29.0 | 31,253,800 |
| FY ending Sep 2019 | ¥1,317 | ¥97.04 | 13.6x | ¥29.0 | 31,253,800 |
| FY ending Sep 2018 | ¥1,792 | ¥112.68 | 15.9x | ¥42.0 | 31,253,800 |
| FY ending Sep 2017 | ¥3,839 | ¥220.63 | 17.4x | ¥48.0 | 15,626,900 |
| FY ending Sep 2016 | ¥2,681 | ¥141.64 | 18.9x | ¥45.0 | 15,626,900 |